Missing/wrong data?
Log in to edit
Long-Term Follow-Up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients With Advanced Melanoma: KEYNOTE-029 Part 1B
scientific article published on 30 June 2020
Author/s
author: Jonathan Cebon, Michael B Jameson, Catriona M McNeil, Nageatte Ibrahim, Georgina V. Long, Antoni Ribas, F Stephen Hodi, Alexander M Menzies, Matteo Carlino
Work details
Publication date
June 30, 2020
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.